Evidence map›Paper›PMID 30794031›Full record

ArticleCancer biology & therapy2019

KCNQ1OT1/miR-217/ZEB1 feedback loop facilitates cell migration and epithelial-mesenchymal transition in colorectal cancer.

Yinzhu Bian, Guangyi Gao, Qun Zhang, Hanqing Qian, Lixia Yu, Ninghua Yao, Jing Qian, Baorui Liu, Xiaoping Qian

Open access · bronzeAbstract read
In one paragraph

Article in Cancer biology & therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Osteosarcoma in a ceRNET perspective.Journal of biomedical science · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Yinzhu Biana Comprehensive Cancer Center , Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University , Nanjing , China.
Guangyi Gaoc Department of Traditional Chinese Medicine , The Affiliated Huai'an Hospital of Xuzhou Medical University and Huai'an Second People's Hospital , Huai'an , Jiangsu , China.
Qun Zhangd Comprehensive Cancer Center, Nanjing Drum Tower Hospital , Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University , Nanjing , China.
Hanqing Qiand Comprehensive Cancer Center, Nanjing Drum Tower Hospital , Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University , Nanjing , China.
Lixia Yud Comprehensive Cancer Center, Nanjing Drum Tower Hospital , Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University , Nanjing , China.
Ninghua Yaoe Radiotherapy of oncology , The Affiliated hospital of Nantong University , Nantong , Jiangsu , China.
Jing Qiane Radiotherapy of oncology , The Affiliated hospital of Nantong University , Nantong , Jiangsu , China.
Baorui Liud Comprehensive Cancer Center, Nanjing Drum Tower Hospital , Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University , Nanjing , China.
Xiaoping Qiana Comprehensive Cancer Center , Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University , Nanjing , China.
Nanjing Drum Tower Hospital · CNAffiliated Hospital of Nantong University · CNNanjing Medical University · CNNantong University · CNXuzhou Medical College · CNYancheng First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long noncoding RNAs are widely acknowledged as a group of regulatory factors in various diseases, especially in cancers. KCNQ1 overlapping transcript 1 (KCNQ1OT1) has been reported as oncogene in human cancers. However, the role of KCNQ1OT1 in colorectal cancer (CRC) has not been fully explained. Based on the database analysis, KCNQ1OT1 was highly expressed in CRC samples and predicted the poor prognosis for CRC patients. Functional experiments revealed that KCNQ1OT1 knockdown negatively affected the proliferation, migration and epithelial-mesenchymal transition (EMT) in CRC cells. Moreover, we identified the cytoplasmic localization of KCNQ1OT1 in CRC cells, indicating the post-transcriptional regulation of KCNQ1OT1 on gene expression. Mechanism experiments including RNA Immunoprecipitation (RIP) assay and dual luciferase reporter assays verified that KCNQ1OT1 acted as a competing endogenous RNA (ceRNA) in CRC by sponging microRNA-217 (miR-217) to up-regulate the expression of zinc finger E-box binding homeobox 1 (ZEB1). Further mechanism investigation revealed that ZEB1 enhanced the transcription activity of KCNQ1OT1 by acting as a transcription activator. Finally, rescue assays were designed to demonstrate the effect of KCNQ1OT1-miR-217-ZEB1 feedback loop on proliferation, migration, and EMT of CRC cells. In brief, our research findings revealed that ZEB1-induced upregulation of KCNQ1OT1 improved the proliferation, migration and EMT formation of CRC cells via regulation of miR-217/ZEB1 axis.

Indexed as

AnimalsBiomarkers, TumorCell Line, TumorCell MovementCell ProliferationColorectal NeoplasmsEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHumansMice, KnockoutMicroRNAsPotassium Channels, Voltage-GatedPrognosisRNA InterferenceTranscription, GeneticZinc Finger E-box-Binding Homeobox 1Biomarkers, TumorKCNQ1OT1 long non-coding RNA, humanMicroRNAsMIRN217 microRNA, humanPotassium Channels, Voltage-GatedZEB1 protein, humanZinc Finger E-box-Binding Homeobox 1colorectal cancerKCNQ1OT1migrationmiR-217ZEB1

Identifiers

PMID30794031
PMCPMC6606042
OpenAlexW2917279709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.